These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25804434)

  • 1. Solid state compatibility study and characterization of a novel degradation product of tacrolimus in formulation.
    Rozman Peterka T; Grahek R; Hren J; Bastarda A; Bergles J; Urleb U
    J Pharm Biomed Anal; 2015 Jun; 110():67-75. PubMed ID: 25804434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multidisciplinary approach to identify a degradation product in a pharmaceutical dosage form.
    Pan C; Guan J; Lin M
    J Pharm Biomed Anal; 2011 Mar; 54(4):855-9. PubMed ID: 21129882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and structure elucidation of a new degradation impurity in the multi-component tablets of amlodipine besylate.
    Gibala P; Douša M; Kalužíková A; Tkadlecová M; Štefko M; Kalášek S; Břicháč J
    J Pharm Biomed Anal; 2019 Jan; 162():112-116. PubMed ID: 30236818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some transformations of tacrolimus, an immunosuppressive drug.
    Skytte DM; Jaroszewski JW; Johansen KT; Hansen SH; Hansen L; Nielsen PG; Frydenvang K
    Eur J Pharm Sci; 2013 Feb; 48(3):514-22. PubMed ID: 23238171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of thermal analysis and pyrolysis coupled to GC-MS in the characterization of tacrolimus.
    Böer TM; Procópio JV; Nascimento TG; Macêdo RO
    J Pharm Biomed Anal; 2013 Jan; 73():18-23. PubMed ID: 22361660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability characterization, kinetics and mechanism of tacrolimus degradation in cyclodextrin solutions.
    Prajapati M; Eiriksson FF; Loftsson T
    Int J Pharm; 2020 Aug; 586():119579. PubMed ID: 32599134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combating Alcohol Adduct Impurity in Immunosuppressant Drug Product Manufacturing: A Scientific Investigation for Enhanced Process Control.
    Sekar V; Vedhachalam D; Vb A; Sivaraman S; Janakarajan V; Sethuraman S; Shiroor SG; Geoffroy JM
    Pharm Res; 2024 May; 41(5):983-1006. PubMed ID: 38561580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and structural elucidation of an unknown impurity in carbamazepine active pharmaceutical ingredient by liquid chromatography-tandem mass spectrometry and semi-preparative chromatographic isolation.
    Thomas S; Mathela CS; Agarwal A; Paul SK
    J Pharm Biomed Anal; 2011 Sep; 56(2):423-8. PubMed ID: 21676571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation kinetics and mechanism of an oxadiazole derivative, design of a stable drug product for BMS-708163, a γ-secretase inhibitor drug candidate.
    Hartley RF; Huang Y; Cassidy M; Razler TM; Qian F; Hussain MA
    J Pharm Sci; 2012 Sep; 101(9):3124-33. PubMed ID: 22262489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-excipient compatibility testing-Identification and characterization of degradation products of phenylephrine in several pharmaceutical formulations against the common cold.
    Douša M; Gibala P; Havlíček J; Plaček L; Tkadlecová M; Břicháč J
    J Pharm Biomed Anal; 2011 Jul; 55(5):949-56. PubMed ID: 21481557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pharmaceutical excipients on the stability of angiotensin-converting enzyme inhibitors in their solid dosage formulations.
    Stanisz B; Regulska K; Kania J; Garbacki P
    Drug Dev Ind Pharm; 2013 Jan; 39(1):51-61. PubMed ID: 22348774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Insight into Chemical Stability of Important Antidiabetic Drug Vildagliptin Using Chromatography (LC-UV and UHPLC-DAD-MS) and Spectroscopy (Mid-IR and NIR with PCA).
    Gumieniczek A; Berecka-Rycerz A; Fornal E; Żyżyńska-Granica B; Granica S
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation, synthesis and characterization of tacrolimus impurities.
    Ferraboschi P; Colombo D; De Mieri M; Grisenti P
    J Antibiot (Tokyo); 2012 Jul; 65(7):349-54. PubMed ID: 22511227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compatibility study between ketoprofen and pharmaceutical excipients used in solid dosage forms.
    Tiţa B; Fuliaş A; Bandur G; Marian E; Tiţa D
    J Pharm Biomed Anal; 2011 Sep; 56(2):221-7. PubMed ID: 21665404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separation and identification of degradation products in eprinomectin formulation using LC, LTQ FT-MS, H/D exchange, and NMR.
    Awasthi A; Razzak M; Al-Kassas R; Greenwood DR; Harvey J; Garg S
    J Pharm Biomed Anal; 2012 Apr; 63():62-73. PubMed ID: 22341479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of oxidative degradation impurities of olanzapine drug substance as well as drug product.
    Rao PS; Ray UK; Hiriyanna SG; Rao SV; Sharma HK; Handa VK; Mukkanti K
    J Pharm Biomed Anal; 2011 Sep; 56(2):413-8. PubMed ID: 21636234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation and structural elucidation of a process related impurity in candesartan cilexetil by LC/ESI-ITMS and NMR.
    Raman B; Sharma BA; Mahale G; Singh D; Kumar A
    J Pharm Biomed Anal; 2011 Sep; 56(2):256-63. PubMed ID: 21664089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of electrochemistry to pharmaceutical stability testing--comparison with in silico prediction and chemical forced degradation approaches.
    Torres S; Brown R; Szucs R; Hawkins JM; Zelesky T; Scrivens G; Pettman A; Taylor MR
    J Pharm Biomed Anal; 2015 Nov; 115():487-501. PubMed ID: 26299525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of humidity and hydroxypropyl cellulose, hydroxypropylmethyl cellulose, glyceryl behenate or magnesium stearate on the degradation kinetics of quinapril hydrochloride in solid phase.
    Stanisz B; Paszun S; Strzyzycka N; Ptaszyński E
    Acta Pol Pharm; 2010; 67(1):99-102. PubMed ID: 20210086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.